For the first time in the Democratic Republic of the Congo (DRC), 13 life-saving health commodities for mothers and children have been included in the National Health Development Plan (NHDP). These medicines are recommended by the United Nations Commission on Life-Saving Commodities for Women and Children (UNCoLSC). The move by the Ministry of Public Health … Read more
In 2012, bedaquiline was conditionally approved by the U.S. Food and Drug Administration for the treatment of drug-resistant tuberculosis (TB), making it the first new TB drug to enter the market in more than 40 years. With the rise of multidrug-resistant and extensively drug-resistant TB leaving patients with fewer treatment options, the approval of bedaquiline … Read more
The WHO End TB Strategy aims to end the global TB epidemic with a three-pronged approach. Targets include reducing TB deaths by 95%, cutting new cases by 90% between 2015 and 2035, and ensuring that no family is burdened with catastrophic expenses due to TB. Our new infographic shows how SIAPS is fighting TB in line with … Read more
In April 2015, USAID and Janssen Therapeutics officially launched the bedaquiline (BDQ) donation initiative, under which Janssen committed to providing free BDQ to 30,000 patients with multidrug-resistant tuberculosis (MDR-TB) over a four-year period. Along with delamanid, BDQ is one of only two new TB medicines released to the market in over 40 years. These medicines … Read more
In April 2015, USAID and Janssen Therapeutics officially launched the bedaquiline (BDQ) donation initiative, under which Janssen committed to providing free BDQ to 30,000 patients with multidrug-resistant tuberculosis (MDR-TB) over a four-year period. Along with delamanid, BDQ is one of only two new TB medicines released to the market in over 40 years. These medicines … Read more
In April 2015, USAID and Janssen Therapeutics officially launched the bedaquiline (BDQ) donation initiative, under which Janssen committed to providing free BDQ to 30,000 patients with multidrug-resistant tuberculosis (MDR-TB) over a four-year period. Along with delamanid, BDQ is one of only two new TB medicines released to the market in over 40 years. These medicines … Read more
In Swaziland, the USAID-funded SIAPS Program has taken great strides in ensuring country ownership and sustainability of local technical assistance initiatives. Since 2012, SIAPS has supported quantification efforts in Swaziland, providing extensive support to the Ministry of Health (MoH) in conducting quantification exercises for antiretrovirals (ARVs), TB medicines, and sexual and reproductive health commodities to … Read more
A 2010 prevalence survey in Pakistan showed that the rate of bacteriologically confirmed pulmonary TB among the adult population is very high. Case detection is important for TB control, allowing service providers to identify sources of infection and treat them to break the chain of infection in a community. For this reason, low TB case … Read more
On March 4, SIAPS Program technical staff presented at the 15th Global Health Mini-University, a one-day learning forum for professionals and students in the field of global health. Hosted by USAID, the George Washington University Milken Institute School of Public Health, and the Global Health Professional and Organizational Development Program, the event featured more than … Read more
On February 25, a central oxygen supply system at Khulna Shishu Hospital (KSH) was inaugurated to ensure that regular and uninterrupted medical oxygen is available for critical management of inpatient children. The central oxygen supply system was commissioned in November 2015, with technical assistance provided by the USAID-funded Systems for Improved Access to Pharmaceuticals and … Read more
